At the European Association of Urology’s 23rd Annual Congress there was an abstract presented (Abstract 186) that concluded that three-dimensional external beam radiation (EBRT) with 6 months of androgen deprivation therapy (ADT) for the treatment of patients with locally advanced prostate cancer shows significantly shorter patient survival than the same treatment followed by 3 years [...]
The following was posted on: http://kittywampus.blogspot.com I have decided to reprint the post, with the author’s permission in its entirety. The author, Dr Patty Stokes (Sungold) is an instructor in Women’s Studies at Ohio University. - Petitioning against Prostate Cancer Most Americans probably know that the women among them face a 1 in 6 lifetime [...]
Gynecomastica is a taboo subject with many men. Men have a hard enough time talking about prostate cancer, but discussing their breast growth is just too much for many. However, many of us who are treated for prostate cancer experience breast growth, gynecomastica. Despite how difficult it is to discuss it, gynecomastica is one of [...]
Sometimes when I write posts I do not stop to think if everyone understands all of the terms I use. It recently came to my attention that not everyone understands all the terminology used about clinical trials. I thought that I would define the most common terms used. Preclinical or Laboratory Studies These studies are [...]
A recent announcement about the once daily oral drug abiraterone acetate (CB7630) indicated that some of the current trial results demonstrate some efficacy in men with hormone refractory prostate cancer. The positive results appeared at two different stages of the standard treatment process. Positive results were demonstrated both before and after the administration of chemotherapy. [...]